Neurological disorders are one of the most feared diseases in the world – they affect almost a billion people worldwide. With populations ageing across the globe, this figure will continue to increase. The only viable solution is to stimulate innovation to produce therapies that slow disease progression and improve the lives of those diagnosed with neurological disorders.

While there is a strong medical need driving research in this area, there are significant challenges to understanding the mechanisms of disease and which are keeping us from reaching new frontiers in innovation.

In recent years, pharmaceutical companies seem to have shifted away from developing their own neurology pipeline, investing instead more heavily into licensing promising drug candidates that originate in biotech companies, where research is currently flourishing.

From 9-12 November, Inova in collaboration with Biotechnology Innovation Organization (BIO), are organizing a 4-day virtual partnering event on neuroscience where participants will have the opportunity to network using the One-on-One Partnering™ platform and showcase their companies through short video presentations or through links to their scientific abstracts.

Through face-to-face meetings, they will discuss the latest research from neurology congresses, learn about emerging start-ups, pitch ideas and partner to prioritize the most promising research efforts.

Participants will be exchanging about topics such as neurodegenerative, neurological and psychiatric diseases, chronic pain, Huntington’s disease, epilepsy, multiple sclerosis, stroke, traumatic brain injury, amyotrophic lateral sclerosis, neurological rare diseases, spinal muscular atrophy and other central and peripheral nervous system disorders.

Registration is open – get your ticket here.